CLEVELAND, Ohio (Wednesday, June 29, 2016)--In an article publishing online today in Menopause, the journal of The North American Menopause Society (NAMS), Rosamar E.F. Rezende, MD, PhD, and colleagues in São Paulo present results of their study testing the efficacy of aerobic exercise in postmenopausal women with nonalcoholic fatty liver disease (NAFLD). NAFLD is considered a cardiovascular disease risk factor, independent of other risk factors, and is associated with insulin resistance, abdominal obesity, hypertension, dyslipidemia, and type 2 diabetes mellitus.